{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T12:37:45Z","timestamp":1784810265402,"version":"3.55.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T00:00:00Z","timestamp":1763510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T00:00:00Z","timestamp":1763510400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Neurol"],"DOI":"10.1186\/s12883-025-04495-9","type":"journal-article","created":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T09:35:21Z","timestamp":1763544921000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Tumefactive demyelinating lesions: a case report and literature review"],"prefix":"10.1186","volume":"25","author":[{"given":"Raneem","family":"Jaki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3885-6803","authenticated-orcid":false,"given":"Zyad","family":"Al-Frejat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziad","family":"Bitar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,19]]},"reference":[{"key":"4495_CR1","doi-asserted-by":"publisher","unstructured":"Wallin MT, Culpepper WJ, Campbell JD, Nelson LM, Langer-Gould A, Marrie RA, et al. The prevalence of MS in the united States. Neurology. 2019;92. https:\/\/doi.org\/10.1212\/WNL.0000000000007035.","DOI":"10.1212\/WNL.0000000000007035"},{"key":"4495_CR2","doi-asserted-by":"publisher","first-page":"153","DOI":"10.17712\/nsj.2024.3.20230111","volume":"29","author":"YM Al Malik","year":"2024","unstructured":"Al Malik YM. Tumefactive demyelinating lesions: A literature review of recent findings. Neurosciences (Riyadh). 2024;29:153\u201360. https:\/\/doi.org\/10.17712\/nsj.2024.3.20230111.","journal-title":"Neurosciences (Riyadh)"},{"key":"4495_CR3","doi-asserted-by":"publisher","first-page":"2279","DOI":"10.1093\/brain\/122.12.2279","volume":"122","author":"C Lucchinetti","year":"1999","unstructured":"Lucchinetti C, Br\u00fcck W, Parisi J, Scheithauer B, Rodriguez M, Lassmann H. A quantitative analysis of oligodendrocytes in multiple sclerosis lesions. Brain. 1999;122:2279\u201395. https:\/\/doi.org\/10.1093\/brain\/122.12.2279.","journal-title":"Brain"},{"key":"4495_CR4","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.msard.2017.04.003","volume":"14","author":"H Algahtani","year":"2017","unstructured":"Algahtani H, Shirah B, Alassiri A. Tumefactive demyelinating lesions: A comprehensive review. Mult Scler Relat Disord. 2017;14:72\u20139. https:\/\/doi.org\/10.1016\/j.msard.2017.04.003.","journal-title":"Mult Scler Relat Disord"},{"key":"4495_CR5","doi-asserted-by":"publisher","first-page":"1544","DOI":"10.1002\/acn3.51844","volume":"10","author":"M Fereidan-Esfahani","year":"2023","unstructured":"Fereidan-Esfahani M, Decker PA, Weigand SD, Lopez Chiriboga AS, Flanagan EP, Tillema J-M, et al. Defining the natural history of tumefactive demyelination: A retrospective cohort of 257 patients. Ann Clin Transl Neurol. 2023;10:1544\u201355. https:\/\/doi.org\/10.1002\/acn3.51844.","journal-title":"Ann Clin Transl Neurol"},{"key":"4495_CR6","doi-asserted-by":"publisher","first-page":"195","DOI":"10.2214\/ajr.182.1.1820195","volume":"182","author":"CA Given","year":"2004","unstructured":"Given CA, Stevens BS, Lee C. The MRI appearance of tumefactive demyelinating lesions. Am J Roentgenol. 2004;182:195\u20139. https:\/\/doi.org\/10.2214\/ajr.182.1.1820195.","journal-title":"Am J Roentgenol"},{"key":"4495_CR7","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.ncl.2004.09.002","volume":"23","author":"CF Lucchinetti","year":"2005","unstructured":"Lucchinetti CF, Parisi J, Bruck W. The pathology of multiple sclerosis. Neurol Clin. 2005;23:77\u2013105. https:\/\/doi.org\/10.1016\/j.ncl.2004.09.002.","journal-title":"Neurol Clin"},{"key":"4495_CR8","doi-asserted-by":"publisher","DOI":"10.1007\/s11910-013-0403-y","volume":"13","author":"AJ Solomon","year":"2013","unstructured":"Solomon AJ, Weinshenker BG. Misdiagnosis of multiple sclerosis: frequency, causes, effects, and prevention. Curr Neurol Neurosci Rep. 2013;13:403. https:\/\/doi.org\/10.1007\/s11910-013-0403-y.","journal-title":"Curr Neurol Neurosci Rep"},{"issue":"1","key":"4495_CR9","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-52048-w","volume":"14","author":"T Ongphichetmetha","year":"2024","unstructured":"Ongphichetmetha T, Aungsumart S, Siritho S, Apiwattanakul M, Tanboon J, Rattanathamsakul N, et al. Tumefactive demyelinating lesions: a retrospective cohort study in Thailand. Sci Rep. 2024;14(1):1426. https:\/\/doi.org\/10.1038\/s41598-024-52048-w.","journal-title":"Sci Rep"},{"key":"4495_CR10","doi-asserted-by":"publisher","unstructured":"Gaillard F, Hooi Hooi T, Vla\u0161i\u010dek I. Tumefactive demyelinating lesion. Radiopaedia.org, Radiopaedia.org; 2008. https:\/\/doi.org\/10.53347\/rID-2225.","DOI":"10.53347\/rID-2225"},{"key":"4495_CR11","doi-asserted-by":"publisher","first-page":"e31899","DOI":"10.7759\/cureus.31899","volume":"14","author":"R Muddassir","year":"2022","unstructured":"Muddassir R, Badirah SB, Alshahrani GM, Eltahan AA. Diagnostic challenges and radiological spectrum of tumefactive multiple sclerosis: A case report study. Cureus. 2022;14:e31899. https:\/\/doi.org\/10.7759\/cureus.31899.","journal-title":"Cureus"},{"key":"4495_CR12","doi-asserted-by":"publisher","unstructured":"S B, J E, G B, A W, F L, S M, et al. Therapeutic plasma exchange in steroid-refractory multiple sclerosis relapses. A retrospective two-center study. Ther Adv Neurol Disord 2021;14. https:\/\/doi.org\/10.1177\/1756286420975642.","DOI":"10.1177\/1756286420975642"},{"key":"4495_CR13","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1212\/WNL.58.1.143","volume":"58","author":"M Keegan","year":"2002","unstructured":"Keegan M, Pineda AA, McClelland RL, Darby CH, Rodriguez M, Weinshenker BG. Plasma exchange for severe attacks of CNS demyelination: predictors of response. Neurology. 2002;58:143\u20136. https:\/\/doi.org\/10.1212\/WNL.58.1.143.","journal-title":"Neurology"},{"key":"4495_CR14","first-page":"307","volume":"12","author":"M van der Velden","year":"1979","unstructured":"van der Velden M, Bots GT, Endtz LJ. Cranial CT in multiple sclerosis showing a mass effect. Surg Neurol. 1979;12:307\u201310.","journal-title":"Surg Neurol"},{"key":"4495_CR15","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1136\/jnnp.45.9.802","volume":"45","author":"H Sagar","year":"1982","unstructured":"Sagar H, Warlow C, Sheldon P, Esiri M. Multiple sclerosis with clinical and radiological features of cerebral tumour. J Neurol Neurosurg Psychiatry. 1982;45:802\u20138. https:\/\/doi.org\/10.1136\/jnnp.45.9.802.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"4495_CR16","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2023.1092373","volume":"14","author":"T Boyle","year":"2023","unstructured":"Boyle T, Fernando SL, Drummond J, Fontes A, Parratt J. Phenotyping variants of tumefactive demyelinating lesions according to clinical and radiological features-a case series. Front Neurol. 2023;14:1092373. https:\/\/doi.org\/10.3389\/fneur.2023.1092373.","journal-title":"Front Neurol"},{"key":"4495_CR17","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1016\/j.autrev.2014.01.012","volume":"13","author":"R Milo","year":"2014","unstructured":"Milo R, Miller A. Revised diagnostic criteria of multiple sclerosis. Autoimmun Rev. 2014;13:518\u201324. https:\/\/doi.org\/10.1016\/j.autrev.2014.01.012.","journal-title":"Autoimmun Rev"},{"key":"4495_CR18","doi-asserted-by":"publisher","unstructured":"Sharma R, Gaillard F, Bell D. McDonald diagnostic criteria for multiple sclerosis. Radiopaedia.org, Radiopaedia.org; 2018. https:\/\/doi.org\/10.53347\/rID-57578.","DOI":"10.53347\/rID-57578"},{"key":"4495_CR19","doi-asserted-by":"publisher","unstructured":"Pereira FV, Jarry V, de Castro M, Appenzeller JTS, Reis S. F. Pediatric inflammatory demyelinating disorders and mimickers: how to differentiate with MRI? Autoimmun Rev 2021;20. https:\/\/doi.org\/10.1016\/j.autrev.2021.102801.","DOI":"10.1016\/j.autrev.2021.102801"},{"key":"4495_CR20","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0069919","volume":"8","author":"Y-C Kuan","year":"2013","unstructured":"Kuan Y-C, Wang K-C, Yuan W-H, Tsai C-P. Tumefactive multiple sclerosis in Taiwan. PLoS ONE. 2013;8:e69919. https:\/\/doi.org\/10.1371\/journal.pone.0069919.","journal-title":"PLoS ONE"},{"key":"4495_CR21","doi-asserted-by":"publisher","first-page":"e41845","DOI":"10.7759\/cureus.41845","volume":"15","author":"J ElSaygh","year":"2023","unstructured":"ElSaygh J, Kandinova N, Zaher A, Sunner GK, Kostanyan S. Tumefactive multiple sclerosis: challenges with treatment modalities. Cureus. 2023;15:e41845. https:\/\/doi.org\/10.7759\/cureus.41845.","journal-title":"Cureus"},{"key":"4495_CR22","doi-asserted-by":"publisher","first-page":"203","DOI":"10.4132\/jptm.2025.05.20","volume":"59","author":"RA Multz","year":"2025","unstructured":"Multz RA, Jamshidi P, Ahrendsen JT. Multiple sclerosis: a practical review for pathologists. J Pathol Transl Med. 2025;59:203\u201313. https:\/\/doi.org\/10.4132\/jptm.2025.05.20.","journal-title":"J Pathol Transl Med"},{"key":"4495_CR23","doi-asserted-by":"publisher","first-page":"4615","DOI":"10.1007\/s00018-021-03802-0","volume":"78","author":"J Spaas","year":"2021","unstructured":"Spaas J, van Veggel L, Schepers M, Tiane A, van Horssen J, Wilson DM, et al. Oxidative stress and impaired oligodendrocyte precursor cell differentiation in neurological disorders. Cell Mol Life Sci. 2021;78:4615\u201337. https:\/\/doi.org\/10.1007\/s00018-021-03802-0.","journal-title":"Cell Mol Life Sci"},{"key":"4495_CR24","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2022.868525","author":"AG Vakrakou","year":"2022","unstructured":"Vakrakou AG, Brinia M-E, Svolaki I, Argyrakos T, Stefanis L, Kilidireas C. Immunopathology of tumefactive demyelinating lesions-from idiopathic to drug-related cases. Front Neurol. 2022. https:\/\/doi.org\/10.3389\/fneur.2022.868525.","journal-title":"Front Neurol"},{"issue":"Pt 10","key":"4495_CR25","doi-asserted-by":"publisher","first-page":"1933","DOI":"10.1093\/BRAIN\/122.10.1933","volume":"122","author":"N De Stefano","year":"1999","unstructured":"De Stefano N, Narayanan S, Matthews PM, Francis GS, Antel JP, Arnold DL. In vivo evidence for axonal dysfunction remote from focal cerebral demyelination of the type seen in multiple sclerosis. Brain. 1999;122(Pt 10):1933\u20139. https:\/\/doi.org\/10.1093\/BRAIN\/122.10.1933.","journal-title":"Brain"},{"key":"4495_CR26","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1590\/S0004-282X2004000300010","volume":"62","author":"AV Faria","year":"2004","unstructured":"Faria AV, Reis F, Zanardi VA, Menezes JR, Cendes F. The pattern of proton magnetic resonance spectroscopy in non-neoplastic encephalic lesions. Arq Neuropsiquiatr. 2004;62:429\u201336. https:\/\/doi.org\/10.1590\/S0004-282X2004000300010.","journal-title":"Arq Neuropsiquiatr"},{"key":"4495_CR27","doi-asserted-by":"publisher","first-page":"186","DOI":"10.2214\/AJR.20.23226","volume":"217","author":"M Nakayama","year":"2021","unstructured":"Nakayama M, Naganawa S, Ouyang M, Jones KA, Kim J, Capizzano AA, et al. A review of clinical and imaging findings in tumefactive demyelination. Am J Roentgenol. 2021;217:186\u201397. https:\/\/doi.org\/10.2214\/AJR.20.23226.","journal-title":"Am J Roentgenol"},{"key":"4495_CR28","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.msard.2018.08.025","volume":"26","author":"R Ikeguchi","year":"2018","unstructured":"Ikeguchi R, Shimizu Y, Abe K, Shimizu S, Maruyama T, Nitta M, et al. Proton magnetic resonance spectroscopy differentiates tumefactive demyelinating lesions from gliomas. Mult Scler Relat Disord. 2018;26:77\u201384. https:\/\/doi.org\/10.1016\/j.msard.2018.08.025.","journal-title":"Mult Scler Relat Disord"},{"key":"4495_CR29","doi-asserted-by":"publisher","first-page":"685","DOI":"10.3174\/ajnr.A5089","volume":"38","author":"SB Hiremath","year":"2017","unstructured":"Hiremath SB, Muraleedharan A, Kumar S, Nagesh C, Kesavadas C, Abraham M, et al. Combining diffusion tensor metrics and DSC perfusion imaging: can it improve the diagnostic accuracy in differentiating tumefactive demyelination from high-grade glioma? Am J Neuroradiol. 2017;38:685\u201390. https:\/\/doi.org\/10.3174\/ajnr.A5089.","journal-title":"Am J Neuroradiol"},{"key":"4495_CR30","doi-asserted-by":"publisher","DOI":"10.1093\/braincomms\/fcaf011","author":"KM Gillen","year":"2024","unstructured":"Gillen KM, Nguyen TD, Dimov A, Kovanlikaya I, Luu HM, Demmon E, et al. Quantitative susceptibility mapping is more sensitive and specific than phase imaging in detecting chronic active multiple sclerosis lesion rims: pathological validation. Brain Commun. 2024. https:\/\/doi.org\/10.1093\/braincomms\/fcaf011.","journal-title":"Brain Commun"},{"key":"4495_CR31","doi-asserted-by":"publisher","first-page":"685","DOI":"10.3174\/AJNR.A5089","volume":"38","author":"SB Hiremath","year":"2017","unstructured":"Hiremath SB, Muraleedharan A, Kumar S, Nagesh C, Kesavadas C, Abraham M, et al. Combining diffusion tensor metrics and DSC perfusion imaging: can it improve the diagnostic accuracy in differentiating tumefactive demyelination from High-Grade glioma? AJNR Am J Neuroradiol. 2017;38:685\u201390. https:\/\/doi.org\/10.3174\/AJNR.A5089.","journal-title":"AJNR Am J Neuroradiol"},{"key":"4495_CR32","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.53786","author":"S Vilayet","year":"2024","unstructured":"Vilayet S, Hayes E, Barakat M, Budisavljevic M, Achanti A. Therapeutic plasma exchange for Treatment-Resistant tumefactive demyelinating lesion: A case report. Cureus. 2024. https:\/\/doi.org\/10.7759\/cureus.53786.","journal-title":"Cureus"},{"key":"4495_CR33","doi-asserted-by":"publisher","first-page":"1338","DOI":"10.1136\/JNNP-2013-305456","volume":"84","author":"AP Sempere","year":"2013","unstructured":"Sempere AP, Feliu-Rey E, Sanchez-Perez R, Nieto-Navarro J. Rituximab for tumefactive demyelination refractory to corticosteroids and plasma exchange. J Neurol Neurosurg Psychiatry. 2013;84:1338\u20139. https:\/\/doi.org\/10.1136\/JNNP-2013-305456.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"4495_CR34","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1177\/1352458507087135","volume":"14","author":"JR Berger","year":"2008","unstructured":"Berger JR. Paradoxically aggressive multiple sclerosis in the face of natalizumab therapy. Mult Scler. 2008;14:708\u201310. https:\/\/doi.org\/10.1177\/1352458507087135.","journal-title":"Mult Scler"}],"container-title":["BMC Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-025-04495-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12883-025-04495-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-025-04495-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T09:35:22Z","timestamp":1763544922000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcneurol.biomedcentral.com\/articles\/10.1186\/s12883-025-04495-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,19]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4495"],"URL":"https:\/\/doi.org\/10.1186\/s12883-025-04495-9","relation":{},"ISSN":["1471-2377"],"issn-type":[{"value":"1471-2377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,19]]},"assertion":[{"value":"12 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was obtained from the patient for publication of this case report and any accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"475"}}